ASK REDCHAT ANYTHING ABOUT PROTARA THERAPEUTICS INC.
Protara Therapeutics Inc. (NASDAQ: TARA)
Listen to this Section
$4.31
-0.0100
(
-0.23% )
0.1K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| IV Choline chlorideDetailsLiver disease, Intestinal failure associated liver disease |
Phase 3 |
| TARA-002DetailsBladder cancer, Non-muscle invasive bladder cancer, Lymphatic malformations, Cancer, Solid tumor/s |
Phase 2 |
| TARA-002DetailsNon-muscle invasive bladder cancer, Bladder cancer |
Phase 1b |
| TARA-002DetailsLymphatic malformations, Bladder cancer, Non-muscle invasive bladder cancer, Cancer, Solid tumor/s |
Phase 2 |
| TARA-002DetailsBladder cancer, Non-muscle invasive bladder cancer |
Phase 2 |
Market Data
|
| Open |
$4.31 |
| Previous Close |
$4.32 |
| Volume |
0.1K |
| Market Cap |
$242.80M |
| Day Range |
$4.22 - $4.32 |
| 52 Week Range |
$2.97 - $7.82 |
| Shares Outstanding |
56.20M |
| Change % |
-0.23% |
| Net Change |
▼ -0.0100 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2020 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-394,479.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-10 |
Sale |
-10000.00 |
Solomon Michael Edward |
| 2024-06-10 |
Sale |
-10000.00 |
Smith Cynthia |
| 2024-06-10 |
Sale |
-10000.00 |
SARGEN GREGORY |
| 2024-06-10 |
Sale |
-10000.00 |
Flannelly Barry P |
| 2024-05-31 |
Sale |
-9230.00 |
Opaleye Management Inc. |
| 2024-05-23 |
Sale |
-31200.00 |
Opaleye Management Inc. |
| 2024-05-17 |
Sale |
-47250.00 |
Opaleye Management Inc. |
| 2024-05-10 |
Sale |
-30600.00 |
Opaleye Management Inc. |
| 2024-01-23 |
Sale |
-59000.00 |
Shefferman Jesse |
| 2024-01-23 |
Sale |
-8000.00 |
Fry Hannah |